Skip to main content

Breast Cancer, Metastatic News (Page 5)

Related terms: Metastatic Breast Cancer

FDA Approves Halaven for Late-Stage Breast Cancer

SILVER SPRING, Md., Nov. 15, 2010 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate) to treat patients with metastatic breast cancer who have...

FDA Approves Herceptin For HER2-Positive Metastatic Stomach Cancer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 20, 2010 - Genentech, a member of the Roche Group, today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab)...

FDA Approves New Dosing for Faslodex (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women

WILMINGTON, Del., Sept. 10 /PRNewswire-FirstCall/ – AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of Faslodex (fulvestrant) Injection,...

GSK's Tykerb Receives Accelerated Approval for First-Line Combination Treatment of Metastatic Breast Cancer

PHILADELPHIA, Jan. 29 /PRNewswire/ – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using Tykerb...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Breast Cancer

Related drug support groups

anastrozole, letrozole, Arimidex, Herceptin, Femara, trastuzumab, tamoxifen, Ibrance